Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

Millions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic myeloid leukemia (CML), advancements in treatment selection could ...

Dr. Suresh Advani, Director, Department of Medical Oncology at Jaslok Hospital & Research Centre, “Effectively managing Chronic Myeloid Leukemia (CML) goes beyond the initial treatment phase.

The introduction of the drug imatinib in 2001 revolutionized the treatment of a type of cancer called chronic myelogenous leukemia. In more than 80% of people with CML who received the drug ...

Brian J. Druker describes how his research on imatinib validated protein kinases as therapeutic targets for cancer and led to a life-saving treatment for leukemia.

Chronic myelogenous leukemia (CML) is a rare blood cancer caused by a chromosomal abnormality that ... Stem cell transplantation is the most effective treatment for CML. However, many patients can ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of ... refractory advanced-phase chronic myeloid leukemia (CML) -- including both ...

Myeloproliferative neoplasms are blood cancers that affect myeloid stem cells ... Some might also receive treatment for anemia. The outlook for CML has improved in recent years with the ...